Hematopoietic and Lymphatic System Neoplasm Clinical Trials in Portland, Oregon

5 studies are recruiting for hematopoietic and lymphatic system neoplasm in Portland, Oregon right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

   This study aims to learn more about symptoms that patients experience while receiving immunotherapy for cancer.

   Stage

   Not phased

   Ages

   18 and older

   Site

   OHSU Knight Cancer Institute, Portland, Oregon

   Run by

   OHSU Knight Cancer Institute

   See if you can join NCT06562777 on ClinicalTrials.gov

2. Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

   This phase III trial compares the effect of giving triptorelin vs no triptorelin in preventing ovarian damage in adolescents and young adults (AYAs) with cancer receiving chemotherapy with alkylating agents. Alkylating agents are part of standard chemotherapy, but may cause damage to the ovaries. I…

   Stage

   Phase 3

   Ages

   Up to 39

   Site

   Oregon Health and Science University, Portland, Oregon

   Locations

   206 in total

   Run by

   Children's Oncology Group

   See if you can join NCT06513962 on ClinicalTrials.gov

3. CREATE: Art for Children With Cancer

   This clinical trial is being done to develop and test how well creative arts interventions (drawing, painting, making sculptures) compared to watching videos can affect symptoms and impact the quality of life in children with cancer. Creative arts mind-body interventions (CrA) are one type of compl…

   Stage

   Not phased

   Ages

   8 to 13

   Site

   OHSU Knight Cancer Institute, Portland, Oregon

   Run by

   OHSU Knight Cancer Institute

   See if you can join NCT06342453 on ClinicalTrials.gov

4. Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

   This phase II trial tests how well cytarabine (Ara-C), methotrexate, and hydrocortisone given between the spinal cord and the membranes that protect it (intrathecal [IT]) works in preventing high-grade immune effector-associated neurotoxicity syndrome (ICANS) in patients receiving chimeric antigen …

   Stage

   Phase 2

   Ages

   18 and older

   Site

   OHSU Knight Cancer Institute, Portland, Oregon

   Run by

   OHSU Knight Cancer Institute

   See if you can join NCT06895473 on ClinicalTrials.gov

5. A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

   This clinical trial tests the impact of a culturally-tailored home-based physical activity program on physical fitness in Hispanic or Latino/Latina adolescent and young adult (AYA) childhood cancer survivors. After treatment for cancer, some AYA survivors experience long-term effects from the cance…

   Stage

   Phase 2

   Ages

   15 to 20

   Site

   Legacy Emanuel Children's Hospital, Portland, Oregon

   Locations

   77 in total

   Run by

   Children's Oncology Group

   See if you can join NCT06410209 on ClinicalTrials.gov